Total Return chart Amplia Therapeutics Limited

Stocks

Market Closed - Australian S.E. 05:10:27 02/11/2026 GMT			5-day change	1st Jan Change
0.0840 ^AUD	0.00%		+7.69%	-44.00%

09-15	Amplia Therapeutics, ANZGOG Finalize Protocol for Phase Two Ovarian Cancer Trial; Shares Up 4%	MT
08-04	Amplia Therapeutics to Evaluate Combination Therapy for Non-Small Cell Lung Cancer in Collaboration With Eli Lilly; Shares Rise 7%	MT

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.